Casa
shitara

Kohei shitara (@KoheiShitara) / X

Por um escritor misterioso

Descrição
Kohei shitara (@KoheiShitara) / X
Kohei SHITARA, Chief, Department of Gastrointestinal Oncolology
Kohei shitara (@KoheiShitara) / X
Pembrolizumab/Placebo Plus Trastuzumab Plus Chemotherapy in Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-811/KEYNOTE-811)
Kohei shitara (@KoheiShitara) / X
Kohei SHITARA, Chief, Department of Gastrointestinal Oncolology
Kohei shitara (@KoheiShitara) / X
Raghav Sundar (@sundar__raghav) / X
Kohei shitara (@KoheiShitara) / X
Kohei SHITARA, Chief, Department of Gastrointestinal Oncolology
Kohei shitara (@KoheiShitara) / X
Kohei SHITARA, Chief, Department of Gastrointestinal Oncolology
Kohei shitara (@KoheiShitara) / X
Raghav Sundar (@sundar__raghav) / X
Kohei shitara (@KoheiShitara) / X
Kohei SHITARA, Chief, Department of Gastrointestinal Oncolology
Kohei shitara (@KoheiShitara) / X
Kohei shitara (@KoheiShitara) / X
Kohei shitara (@KoheiShitara) / X
Kohei shitara (@KoheiShitara) / X
Kohei shitara (@KoheiShitara) / X
Susumu Kobayashi (@SusumuKobayas10) / X
Kohei shitara (@KoheiShitara) / X
Oncology Data Advisor - Zolbetuximab: Gastric/Gastroesophageal Junction Adenocarcinoma
Kohei shitara (@KoheiShitara) / X
Kohei shitara (@KoheiShitara) / X
de por adulto (o preço varia de acordo com o tamanho do grupo)